探索骨质甘油在2型糖尿病中的作用:对胰岛素抵抗和血管病理生理学的影响
Sheila González-Salvatierra1,2,3, Beatriz García-Fontana1,2,4,5, Luis Martínez-Heredia1
1Biosanitary Research Institute of Granada (ibs.GRANADA), Granada, Spain.
在2型糖尿病 (T2D) 患者中,血清骨质甘氨酸水平升高,与胰岛素抵抗标志物相关. 血管细胞中的骨质甘氨酸过度表达促进了增殖和自毒素的表达,这表明在T2D相关的心血管并发症中发挥了作用.
科学领域:
- 生物化学 生物化学
- 内分泌学 在内分泌学.
- 血管生物学 血管生物学
背景情况:
- 骨质甘氨酸是血管细胞外基质中的蛋白质甘氨酸,在血管光滑肌细胞 (VSMC) 中表达.
- 骨质甘油在2型糖尿病 (T2D) 中心血管疾病 (CVD) 发展中的作用尚不清楚.
- T2D是心血管疾病的重要危险因素.
研究的目的:
- 为了比较T2D患者有或没有心血管疾病的血清和血管骨质甘氨酸水平与对照.
- 在化条件下研究骨质糖素在VSMC中的体外作用.
主要方法:
- 与酶相关的免疫吸收试验 (ELISA) 对血清骨质糖的检测.
- 对于血管骨质甘氨酸表达的RT-qPCR和免疫组织化学.
- 在化条件下使用VSMCs与模拟和骨质甘油过度表达的体外研究.
主要成果:
- 与对照组相比,T2D患者的血清骨质甘氨酸水平显著增加.
- 骨质甘氨酸水平与胰岛素耐药性标志物 (甘油三,TG/HDL-C指数) 相相关,但不存在心血管疾病.
- 血管骨质甘氨酸表达在T2D和对照组之间没有显著差异.
- 在VSMC中的骨质甘氨酸过度表达增加了细胞增殖和在化条件下上调自毒素 (ATX) 表达.
结论:
- 骨质甘氨酸可能在血糖平衡中发挥作用,并作为T2D中胰岛素抵抗的潜在生物标志物.
- 骨质甘油可能通过调节ATX并促进VSMC增殖来间接促进动脉样硬化的发展.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Proteoglycans
Insulin: The Receptor and Signaling Pathways
